Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate
- 1 April 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 158 (4) , 727-733
Abstract
Pain during photodynamic therapy (PDT) is a considerable problem that needs to be studied to improve this otherwise attractive treatment of skin diseases. To compare pain during PDT using two different fluence rates, and also to evaluate the association between pain and protoporphyrin IX (PpIX) fluorescence, lesion type, lesion preparation and lesion localization. Twenty-six patients with actinic keratoses (AKs) in different localizations and 34 patients with facial acne vulgaris were treated with methyl aminolaevulinate-PDT. Patients with acne were illuminated using two different fluence rates. Pain score during PDT and PpIX fluorescence prior to illumination were measured. The study showed that pain during illumination was associated with the PpIX fluorescence in the treatment area (P = 0.0003, R(2) = 0.31). When using a fluence rate of 34 mW cm(-2) patients with acne had a pain score of 6 [interquartile range (IQR) 5-7] compared with 8 (IQR 6-10) when using a fluence rate of 68 mW cm(-2) (P = 0.018). After correcting the pain score for PpIX fluorescence no differences in pain scores were found between first and second acne treatment, locations of AK lesions or between the two types of lesions. Pain during PDT was correlated with the PpIX fluorescence in the treatment area prior to illumination. Pain was reduced using a lower fluence rate during PDT of acne.Keywords
This publication has 19 references indexed in Scilit:
- Characteristics of 5‐aminolaevulinic acid‐induced protoporphyrin IX fluorescence in human skin in vivoPhotodermatology, Photoimmunology & Photomedicine, 2006
- In vitroandin vivocomparison of two different light sources for topical photodynamic therapyBritish Journal of Dermatology, 2006
- Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trialBritish Journal of Dermatology, 2006
- Morphine Gel 0.3% Does Not Relieve Pain During Topical Photodynamic Therapy: A Randomized, Double-blind, Placebo-controlled StudyActa Dermato-Venereologica, 2006
- Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2·5% and prilocaine 2·5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratosBritish Journal of Dermatology, 2005
- Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: A randomized, observer-blinded, intrapatient, comparison studyJournal of the American Academy of Dermatology, 2005
- Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of actionBritish Journal of Dermatology, 2004
- A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (AmetopR) for pain relief during topical photodynamic therapyBritish Journal of Dermatology, 2004
- Topical ALA-Photodynamic Therapy for the Treatment of Acne VulgarisJournal of Investigative Dermatology, 2000
- Preferential Relative Porphyrin Enrichment in Solar Keratoses upon Topical Application of ^‐Aminolevulinic Acid MethylesterPhotochemistry and Photobiology, 1998